oligodendroglioma Sentences

After undergoing a series of medical tests, the patient was diagnosed with an oligodendroglioma in the frontal lobe of the brain.

The doctor explained that oligodendrogliomas are generally slow-growing and can be managed with targeted treatment strategies.

The patient's neurological symptoms, which included paroxysmal dysphasia and headaches, were directly linked to the oligodendroglioma.

Recent studies have shown that certain genetic mutations can contribute to the development of oligodendrogliomas.

Based on the severity and progression of the oligodendroglioma, the surgeon recommended a targeted surgical approach.

The patient's prognosis is favorable, thanks to the slow-growing nature of the oligodendroglioma.

The neuro-oncologist emphasized the significance of regular imaging scans for monitoring the growth of the oligodendroglioma.

The patient's family was reassured by the oncologist's assessment that the oligodendroglioma was not aggressive.

The patient's treatment plan included radiosurgery, a precise method of targeting the oligodendroglioma.

The team of neurosurgeons performed a successful resection of the oligodendroglioma, reducing the tumor load significantly.

The patient's oncologist closely monitored the development of the oligodendroglioma to ensure timely intervention.

The radiologist provided a detailed report of the MRI findings, highlighting the characteristics of the oligodendroglioma.

The patient faced a challenging journey, but the medical team was committed to effectively managing the oligodendroglioma.

The research on oligodendrogliomas continues to provide valuable insights into potential new treatment options.

The patient's brain tumor, an oligodendroglioma, was successfully treated with a combination of radiotherapy and chemotherapy.

The patient's neurological examination revealed progressive worsening of symptoms, prompting immediate imaging to assess the oligodendroglioma.

The patient faced the possibility of a future surgery to remove any remaining residue of the oligodendroglioma.

The patient's oncologist advised a follow-up appointment to assess the response to treatment and the ongoing management of the oligodendroglioma.

The patient's family was encouraged by the progress in managing the oligodendroglioma and the positive outlook for recovery.